Dublin, 7th September, 2012: Dr Manus Rogan, managing partner and co-founder of Fountain Healthcare Partners, has been elected chairman of the Irish Venture Capital Association (IVCA). He succeeds Maurice Roche, partner in Delta Partners.
The Irish Venture Capital Association is the representative organisation for venture capital firms in Ireland. In the last ten years Irish VCs have invested €1.5bn into Irish SMEs and have attracted an additional €1.5bn from international VCs through syndication.
Dr Rogan has over 23 years investment and operating experience in the life science sector in the US, Europe and Japan. He began his career at GlaxoSmithKline in the UK. In 1996 he joined Elan Corporation where he concluded over 25 investment and technology licensing transactions globally. He currently serves on the board of Opsona Therapeutics and until recently represented Fountain Healthcare Partners on the Amarin Corporation board.
Dr Rogan holds a PhD in chemistry from the University of York (sponsored by GlaxoSmithKline) and an MBA from Trinity College Dublin.